Overall survival and response pattern of castration-resistant metastatic prostate cancer to multiple cycles of radioligand therapy using [177Lu]Lu-PSMA-617
Crossref DOI link: https://doi.org/10.1007/s00259-017-3716-2
Published Online: 2017-05-09
Published Print: 2017-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Ahmadzadehfar, Hojjat
Wegen, Simone
Yordanova, Anna
Fimmers, Rolf
Kürpig, Stefan
Eppard, Elisabeth
Wei, Xiao
Schlenkhoff, Carl
Hauser, Stefan
Essler, Markus
License valid from 2017-05-09